Appeal Rejected in Hormone Replacement Drug Case
The United States Supreme Court has rejected Pfizer’s appeal of a $2.7 million verdict resulting from its Prempro hormone-replacement treatment being linked to breast cancer. Pfizer requested the appeal after a lower court upheld the compensatory award of $2.7 million..
Follow this link:
Appeal Rejected in Hormone Replacement Drug Case
